These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30606013)

  • 21. Effect of trastuzumab interchain disulfide bond cleavage on Fcγ receptor binding and antibody-dependent tumour cell phagocytosis.
    Suzuki M; Yamanoi A; Machino Y; Ootsubo M; Izawa K; Kohroki J; Masuho Y
    J Biochem; 2016 Jan; 159(1):67-76. PubMed ID: 26254483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies.
    Ohata J; Ball ZT
    J Am Chem Soc; 2017 Sep; 139(36):12617-12622. PubMed ID: 28810739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoate-acid ligase a modification of native antibody: Synthesis and conjugation site analysis.
    Yamazaki S; Shikida N; Takahashi K; Matsuda Y; Inoue K; Shimbo K; Mihara Y
    Bioorg Med Chem Lett; 2021 Nov; 51():128360. PubMed ID: 34537330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjugation of a reactive thiol at the nucleotide binding site for site-specific antibody functionalization.
    Alves NJ; Mustafaoglu N; Bilgicer B
    Bioconjug Chem; 2014 Jul; 25(7):1198-202. PubMed ID: 24932680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles.
    Park J; Chariou PL; Steinmetz NF
    Bioconjug Chem; 2020 May; 31(5):1408-1416. PubMed ID: 32281790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of monoclonal and polyclonal IgG with palladium (II) coproporphyrin I: stimulatory and inhibitory functional effects induced by two different methods.
    Martsev SP; Preygerzon VA; Mel'nikova YI; Kravchuk ZI; Ponomarev GV; Lunev VE; Savitsky AP
    J Immunol Methods; 1995 Oct; 186(2):293-304. PubMed ID: 7594629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.
    Herbener P; Schönfeld K; König M; Germer M; Przyborski JM; Bernöster K; Schüttrumpf J
    PLoS One; 2018; 13(4):e0195823. PubMed ID: 29672587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving target cell specificity using a novel monovalent bispecific IgG design.
    Mazor Y; Oganesyan V; Yang C; Hansen A; Wang J; Liu H; Sachsenmeier K; Carlson M; Gadre DV; Borrok MJ; Yu XQ; Dall'Acqua W; Wu H; Chowdhury PS
    MAbs; 2015; 7(2):377-89. PubMed ID: 25621507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance.
    Jo M; Kwon HS; Lee KH; Lee JC; Jung ST
    MAbs; 2018; 10(2):278-289. PubMed ID: 29173039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules.
    Aigbogun OP; Phenix CP; Krol ES; Price EW
    Mol Pharm; 2023 Feb; 20(2):853-874. PubMed ID: 36696533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability.
    Hamblett KJ; Le T; Rock BM; Rock DA; Siu S; Huard JN; Conner KP; Milburn RR; O'Neill JW; Tometsko ME; Fanslow WC
    Mol Pharm; 2016 Jul; 13(7):2387-96. PubMed ID: 27248573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-Specific Photocrosslinking to Immunoglobulin G Using Photoreactive Antibody-Binding Domains.
    Zappala F; Tsourkas A
    Methods Mol Biol; 2019; 2033():275-286. PubMed ID: 31332760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the antibody-peroxidase coupling methods on the conjugate stability and on the methodologies for the preservation of the activity in time.
    Presentini R; Terrana B
    J Immunoassay; 1995 Aug; 16(3):309-24. PubMed ID: 7593652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation Protection in Metal-Binding Peptide Motif and Its Application to Antibody for Site-Selective Conjugation.
    Chung HS; Lee S; Park SJ
    PLoS One; 2016; 11(7):e0159451. PubMed ID: 27420328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation.
    Patterson JT; Wilson HD; Asano S; Nilchan N; Fuller RP; Roush WR; Rader C; Barbas CF
    Bioconjug Chem; 2016 Oct; 27(10):2271-2275. PubMed ID: 27666414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-bead antibody-small molecule conjugation using high-capacity magnetic beads.
    Nath N; Godat B; Benink H; Urh M
    J Immunol Methods; 2015 Nov; 426():95-103. PubMed ID: 26316179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient strategies for the conjugation of oligonucleotides to antibodies enabling highly sensitive protein detection.
    Kozlov IA; Melnyk PC; Stromsborg KE; Chee MS; Barker DL; Zhao C
    Biopolymers; 2004 Apr; 73(5):621-30. PubMed ID: 15048786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.